A UK-based KOL provides insights into the SLE treatment landscape, highlighting challenges with treatment adherence and drug availability. They also discuss the promise and pitfalls of pipeline drugs and the importance of earlier diagnosis and education for improving patient outcomes. 

This interview was conducted on 3rd September 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.